Skip to content

Clover Health Investments CLOV Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

Humana logo
HumanaHUM
CVS Health logo
CVS HealthCVS
Globe Life logo
Globe LifeGL

Other financials

Income statement

See full
Revenue$749.2M+62.0%
Operating income$27.3M+2,246%
Net income$27.3M+2,246%
EPS (diluted)$0.05

Balance sheet

See full
Cash & equivalents$173.3M+11.5%
Total debt$3.3M-0.9%
Total equity$339.4M+1.0%
Total assets$697.7M+19.5%

Cash flow

See full
Operating cash flow$107.9M+762%
CapEx$854.0K+362%
Free cash flow$107.0M+750%

Valuation

See full
Market cap$2.67B-49.7%
P/S1.2×-2.4×

Profitability

See full
Operating margin-2.6%+3.5pp
Net margin-2.6%+2.8pp
FCF margin-10.3%

Returns & leverage

See full
Return on equity-16.9%-170pp
Debt / equity0.0×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by Clover Health Investments in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: Clover Health Investments’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clover Health Investments's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clover Health Investments's treasury stock, shares (in shares)?
Clover Health Investments (CLOV) reported treasury stock, shares (in shares) of $34.98M in Q1 2026.
How has Clover Health Investments's treasury stock, shares (in shares) changed year-over-year?
Clover Health Investments's treasury stock, shares (in shares) increased by 36.3% year-over-year, from $25.66M to $34.98M.
What is the long-term trend for Clover Health Investments's treasury stock, shares (in shares)?
Over 4 years (2021 to 2025), Clover Health Investments's treasury stock, shares (in shares) has grown at a 590.1% compound annual growth rate (CAGR), from $14.73K to $33.41M.